Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A4H8P1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 103 | 107 | PF00656 | 0.564 |
CLV_C14_Caspase3-7 | 114 | 118 | PF00656 | 0.643 |
CLV_MEL_PAP_1 | 34 | 40 | PF00089 | 0.304 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.704 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.617 |
CLV_PCSK_PC1ET2_1 | 101 | 103 | PF00082 | 0.597 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.596 |
CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.445 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.468 |
DOC_CKS1_1 | 87 | 92 | PF01111 | 0.417 |
DOC_CYCLIN_RxL_1 | 7 | 17 | PF00134 | 0.519 |
DOC_MAPK_HePTP_8 | 24 | 36 | PF00069 | 0.319 |
DOC_MAPK_MEF2A_6 | 27 | 36 | PF00069 | 0.514 |
DOC_MAPK_MEF2A_6 | 45 | 52 | PF00069 | 0.441 |
DOC_PP4_FxxP_1 | 87 | 90 | PF00568 | 0.401 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.623 |
DOC_USP7_UBL2_3 | 10 | 14 | PF12436 | 0.354 |
DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.486 |
LIG_14-3-3_CanoR_1 | 45 | 51 | PF00244 | 0.470 |
LIG_AP2alpha_2 | 85 | 87 | PF02296 | 0.424 |
LIG_BRCT_BRCA1_1 | 108 | 112 | PF00533 | 0.624 |
LIG_BRCT_BRCA1_1 | 48 | 52 | PF00533 | 0.477 |
LIG_FHA_2 | 101 | 107 | PF00498 | 0.550 |
LIG_LIR_Apic_2 | 85 | 90 | PF02991 | 0.448 |
LIG_NRBOX | 8 | 14 | PF00104 | 0.529 |
LIG_PDZ_Class_1 | 115 | 120 | PF00595 | 0.648 |
LIG_Pex14_1 | 83 | 87 | PF04695 | 0.431 |
LIG_PTB_Apo_2 | 66 | 73 | PF02174 | 0.383 |
LIG_PTB_Phospho_1 | 66 | 72 | PF10480 | 0.382 |
LIG_SH2_STAP1 | 72 | 76 | PF00017 | 0.396 |
LIG_SUMO_SIM_anti_2 | 30 | 36 | PF11976 | 0.308 |
LIG_SUMO_SIM_anti_2 | 47 | 52 | PF11976 | 0.407 |
LIG_TRAF2_1 | 75 | 78 | PF00917 | 0.454 |
LIG_UBA3_1 | 65 | 71 | PF00899 | 0.450 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.520 |
MOD_CK2_1 | 27 | 33 | PF00069 | 0.479 |
MOD_CK2_1 | 72 | 78 | PF00069 | 0.551 |
MOD_GlcNHglycan | 28 | 32 | PF01048 | 0.501 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.667 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.637 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.750 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.588 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.544 |
MOD_N-GLC_1 | 115 | 120 | PF02516 | 0.558 |
MOD_N-GLC_1 | 53 | 58 | PF02516 | 0.561 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.590 |
MOD_PKA_1 | 100 | 106 | PF00069 | 0.495 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.569 |
MOD_PKB_1 | 102 | 110 | PF00069 | 0.670 |
MOD_Plk_2-3 | 106 | 112 | PF00069 | 0.645 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.505 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.389 |
MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.492 |
MOD_SUMO_rev_2 | 98 | 103 | PF00179 | 0.579 |
TRG_DiLeu_BaEn_4 | 77 | 83 | PF01217 | 0.480 |
TRG_NLS_MonoExtC_3 | 100 | 106 | PF00514 | 0.626 |
TRG_NLS_MonoExtN_4 | 100 | 105 | PF00514 | 0.678 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAA9 | Leptomonas seymouri | 64% | 94% |
A0A3S5H6Y4 | Leishmania donovani | 81% | 100% |
A0A422NPT6 | Trypanosoma rangeli | 29% | 77% |
C9ZZZ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 75% |
E9ACR6 | Leishmania major | 76% | 100% |
E9AGP1 | Leishmania infantum | 81% | 100% |
E9AQS5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |